During the past decade, Elkerliek Ziekenhuis conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 3 clinical trials were completed, i.e. on average, 12% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elkerliek Ziekenhuis" #1 sponsor was "Dutch Colorectal Cancer Group" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Maastricht University Medical Center" with 3 trials sponsored, "Radboud University Medical Center" with 3 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elkerliek Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 8 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator, "Fonds NutsOhra" with 2 trials as a collaborator, "Innovatiefonds Zorgverzekeraars" with 2 trials as a collaborator and "AO Research Fund" with 1 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "Elkerliek Ziekenhuis" are "Breast Cancer" (3 trials), "Atrial Fibrillation" (2 trials), "Colon Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Elkerliek Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Elkerliek Ziekenhuis" are "Drug" (26 trials), "Other" (6 trials), "Procedure" (6 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cisplatin" (3 trials), "Docetaxel" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials) and "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elkerliek Ziekenhuis" are 36 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Elkerliek Ziekenhuis". undefined are not yet recruiting, 12 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Elkerliek Ziekenhuis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Elkerliek Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".